Kaisernetwork.org is no longer publishing new content as of June 1, 2009.

The Kaiser Family Foundation continues to provide webcasts, podcasts and transcripts of Kaiser's events along with health policy briefings on the Hill conducted by the Alliance for Health Reform. You may access these webcasts, along with Kaiser's original videos and documentaries, on kff.org. All archived webcasts, podcasts and transcripts made available on kaisernetwork.org prior to June 1, 2009, continue to be available on-demand. You may search for webcasts here.

We have detected that your browser blocked our video player. Please enable popups and try again. Thank you. Search for webcasts from November 2000 – May 2009. Access webcasts from June 2009 forward, on kff.org. Open Forum II: Key Issues in TB Drug Development - Day One 12/12/2006 TB Alliance, Bill and Melinda Gates Foundation, Treatment Action Group, Stop TB Partnership Working Group on New Drugs, London, England     Email this Webcast Share Del.icio.us Digg Facebook Google Bookmarks Myspace Reddit   Support Files Choudhri Slides (.pdf) Duncan Slides (.pdf) Gillespie Slides (.pdf) Hittel Slides (.pdf) Laughon Slides (.pdf) Laurenzi Slides (.pdf) Lienhardt Slides (.pdf) McNeeley Slides (.pdf) McNeeley TMC207 Slides (.pdf) Mitchison Slides (.pdf) Muntendam Slides (.pdf) Nacy Slides (.pdf) Nacy SQ109 Slides (.pdf) Nunn Slides (.pdf) Additional Resources Kaisernetwork.org Coverage of the 37th Union World Conference on Lung Health GlobalHealthReporting.org - Tuberculosis GlobalHealthFacts.org GlobalHealthReporting.org Weekly TB/Malaria Report This two-day forum, hosted by the TB Alliance, Bill and Melinda Gates Foundation, Treatment Action Group and the Stop TB Partnership Working Group on New Drugs, is the second in a series of meetings addressing key issues in TB drug development. This forum includes sessions on key issues in the critical path to TB drug registration, biomarkers for TB drug development, designing pivotal trials, conducting registration trials in high burden countries and developing regimens containing multiple novel agents.   December 13 Sessions Full version: Video Transcript Speakers for this session:   Welcome and Introduction Maria Freire, Ph.D. President and Chief Executive Officer TB Alliance Ken Duncan, M.D. Bill and Melinda Gates Foundation     The TB Drug Pipeline – Present and Future Christian Lienhardt, M.D. International Union Against Tuberculosis and Lung Disease  Shurjeel Choudhri Director and Global Clinical Leader Bayer Pharmaceuticals David McNeeley Director, Global Clinical Development for Tibotec Tibotec Norbert Hittel Managing Director Otsuka Pharmaceutical Co., Ltd Martino Laurenzi, M.D., M.P.H. Clinical Research Scientist TB Alliance Carol Nacy, Ph.D. Founder and CEO Sequella, Inc. Full version: Video Transcript Speakers for this session:   Overview of the Global Preclinical and Discovery Portfolio Barbara Laughon, Ph.D. Chief, Complications and Co-Infections Research, Therapeutics Research Program National Institute of Allergy and Infectious Diseases     Feding the Future: the BMGF "Accelerator" Ken Duncan, M.D. Programme Director Bill and Melinda Gates Foundation     Progress and Challenges in Biomarker Development Pieter Muntendamm, M.D. President BG Medicine Full version: Video Transcript Speakers for this session:   Approaches to Proof of Concept and Dose-finding Dennis Mitchison, M.B. Department of Medical Microbiology St. George's Medical School Carol Nacy, Ph.D. Founder and CEO Sequella, Inc.     Key Issues for Pivotal (Phase III) Trials Andrew Nunn Associate Director Medical Research Council    Stephen Gillespie Professor of Medical Microbiology Royal Free & University College Medical School Full version: Video Transcript Speakers for this session:   Approach to Developing A Non-Rifampin-Based First-Line Regimen David McNeeley Director, Global Clinical Development for Tibotec Tibotec EMAIL ALERTS Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news and events.   FAQs How to disable a pop-up blocker How to view a webcast How to listen to a podcast More...   CONTACT US Contact us by email with any comments, problems, suggestions. Call the kaisernetwork.org Help Desk at 202-347-5270. ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... About Us     Help